Ingrid Louise Titlested

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Primary Spontaneous Pneumothorax 27%
3. Noninvasive Ventilation 24%
4. Emergency Medical Technicians 22%
5. Mortality 17%
6. microfibrillar protein 17%
7. Lung Diseases 15%
8. Cohort Studies 14%
9. Pulmonary Surfactant-Associated Protein D 14%
10. Biomarkers 12%
11. Lung 12%
12. Chest Tubes 12%
13. Point-of-Care Systems 11%
14. Feasibility Studies 10%
15. Therapeutics 10%
16. tralokinumab 9%
17. Randomized Controlled Trials 9%
18. Monoclonal Antibodies 8%
19. Pulmonary Medicine 8%
20. Smokers 8%
21. Nemiralisib 8%
22. Eosinophils 8%
23. Asthma 7%
24. Hospitalization 7%
25. Systematic Reviews 7%
26. Volatile Organic Compounds 7%
27. Pulmonary Aspergillosis 7%
28. Prospective Studies 7%
29. Smoke 6%
30. Leukocyte L1 Antigen Complex 6%
31. Pneumothorax 6%
32. Denmark 6%
33. Nontuberculous Mycobacteria 6%
34. Adrenal Cortex Hormones 6%
35. Hospital Emergency Service 6%
36. Sputum 6%
37. Marijuana Smoking 5%
38. Bronchiectasis 5%
39. Psychological Practice 5%
40. Interleukin-13 5%
41. Tobacco 5%
42. Emphysema 5%
43. Telemedicine 5%
44. Respiratory Insufficiency 5%
45. Cannabis 5%